Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
$Genprex, Inc.(GNPX)$ Genprex Inc. has announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering the use of its lead drug candidate, Reqorsa® Gene Therapy, in combination with PD-L1 antibodies, such as Tecentriq®. Additionally, the European Patent Office has issued a Notice of Allowance for a patent covering the use of REQORSA in combination with PD-1 antibodies. Both patents will expire in 2037 at the earliest. These developments enhance Genprex's intellectual property estate for its oncology program involving immune checkpoint inhibitors, specifically applicable to the Acclaim-3 clinical trial. Furthermore, Genprex is pursuing additional patent applications in Europe, Canada, Brazil, China,
$NVIDIA(NVDA)$ hit my trailing SL but was happy with it. i think it's a good time to sell now and see if there is any correction before entering again.